美国 · SEC FORM 4
GeneDx Holdings Corp.
WGS · Nasdaq · CIK 0001818331 · Healthcare · Diagnostics & Research
内部人信号
2 位买方 · 24 条买入交易行 · $93.1M 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase activity is becoming less recent
- ✓ 角色得分高 · 买入者中职位最高的是:Director,TenPercentOwner
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 69.4
- 69.3
- 69.3
- 69.3
- 69.3
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -19.8%
- 3M
- +5.5%
- 6M
- +12.9%
- 12M
- -45.1%
波动率与流动性
- 波动率
- 98.8%
- Beta
- —
- 平均每日成交额
- USD 49.2M
估值
- 市值
- USD 2.0B
- P/E
- —
基本面
- 利润率
- -4.9%
- ROE
- -6.8%
- 细分行业
- Diagnostics & Research
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-07-27 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 5,626,310
- 上期报告
- 5,884,765
- 日均成交量
- 945,488
- 回补天数
- 6.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 50,000 | USD 52.86 | USD 2,643,000 | SEC 申报 ↗ |
| 2026-06-04 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 150,000 | USD 56.44 | USD 8,466,000 | SEC 申报 ↗ |
| 2026-05-20 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 140,000 | USD 43.81 | USD 6,133,400 | SEC 申报 ↗ |
| 2026-05-19 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 185,000 | USD 42.60 | USD 7,881,000 | SEC 申报 ↗ |
| 2026-05-18 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 175,000 | USD 42.55 | USD 7,446,250 | SEC 申报 ↗ |
| 2026-05-15 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 46,273 | USD 38.91 | USD 1,800,571 | SEC 申报 ↗ |
| 2026-05-14 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 140,000 | USD 39.39 | USD 5,514,790 | SEC 申报 ↗ |
| 2026-05-13 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 165,000 | USD 39.09 | USD 6,449,983 | SEC 申报 ↗ |
| 2026-05-11 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 500,000 | USD 39.29 | USD 19,642,789 | SEC 申报 ↗ |
| 2026-05-08 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 171,389 | USD 40.59 | USD 6,956,751 | SEC 申报 ↗ |
| 2026-05-07 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 533,758 | USD 37.86 | USD 20,207,189 | SEC 申报 ↗ |
| 2026-03-05 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 140,026 | USD 81.19 | USD 11,369,152 | SEC 申报 ↗ |
| 2026-03-03 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 29,495 | USD 70.89 | USD 2,090,937 | SEC 申报 ↗ |
| 2025-05-14 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 50,000 | USD 60.16 | USD 3,007,997 | SEC 申报 ↗ |
| 2025-05-08 | Corvex Management LP; Meister Keith A. | 买入 (P) | Class A Common Stock | 100,000 | USD 56.01 | USD 5,600,994 | SEC 申报 ↗ |
Form 4 申报证据
184 transaction lines in the latest 365-day window; 737 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Fuchs Thomas | 期权行权/转换 (M) | Class A Common Stock | 1,146 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-16 | Stueland Katherine | 卖出 (S) | Class A Common Stock | 10,501 | USD 97.61 | USD 1,025,031 | SEC 申报 ↗ |
| 2026-09-16 | Stueland Katherine | 期权行权/转换 (M) | Class A Common Stock | 18,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Fuchs Thomas | 期权行权/转换 (M) | Class A Common Stock | 1,146 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-16 | Stueland Katherine | 卖出 (S) | Class A Common Stock | 10,501 | USD 97.61 | USD 1,025,031 | SEC 申报 ↗ |
| 2026-09-16 | Stueland Katherine | 期权行权/转换 (M) | Class A Common Stock | 18,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-16 | Feeley Kevin | 卖出 (S) | Class A Common Stock | 3,728 | USD 97.61 | USD 363,898 | SEC 申报 ↗ |
| 2026-09-16 | Feeley Kevin | 期权行权/转换 (M) | Class A Common Stock | 7,197 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-09 | Stueland Katherine | 卖出 (S) | Class A Common Stock | 3,692 | USD 84.22 | USD 310,940 | SEC 申报 ↗ |
| 2026-09-09 | Stueland Katherine | 期权行权/转换 (M) | Class A Common Stock | 6,547 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-09 | Feeley Kevin | 卖出 (S) | Class A Common Stock | 1,285 | USD 84.22 | USD 108,223 | SEC 申报 ↗ |
| 2026-09-09 | Feeley Kevin | 期权行权/转换 (M) | Class A Common Stock | 2,462 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Feeley Kevin | 卖出 (S) | Class A Common Stock | 372 | USD 83.84 | USD 31,188 | SEC 申报 ↗ |
| 2026-09-01 | Feeley Kevin | 期权行权/转换 (M) | Class A Common Stock | 717 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Ryan Jason | 期权行权/转换 (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | RUCH JOSHUA | 期权行权/转换 (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | PFENNIGER RICHARD C JR | 期权行权/转换 (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Meister Keith A. | 期权行权/转换 (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Leproust Emily M. | 期权行权/转换 (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Casdin Eli | 期权行权/转换 (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Stueland Katherine | 卖出 (S) | Class A Common Stock | 10,501 | USD 60.76 | USD 638,092 | SEC 申报 ↗ |
| 2026-06-16 | Stueland Katherine | 期权行权/转换 (M) | Class A Common Stock | 18,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Feeley Kevin | 卖出 (S) | Class A Common Stock | 3,729 | USD 60.76 | USD 226,592 | SEC 申报 ↗ |
| 2026-06-16 | Feeley Kevin | 期权行权/转换 (M) | Class A Common Stock | 7,197 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | Stueland Katherine | 卖出 (S) | Class A Common Stock | 3,639 | USD 53.77 | USD 195,669 | SEC 申报 ↗ |
| 2026-06-09 | Stueland Katherine | 期权行权/转换 (M) | Class A Common Stock | 6,546 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | Feeley Kevin | 卖出 (S) | Class A Common Stock | 1,266 | USD 53.77 | USD 68,073 | SEC 申报 ↗ |
| 2026-06-09 | Feeley Kevin | 期权行权/转换 (M) | Class A Common Stock | 2,462 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 50,000 | USD 52.86 | USD 2,643,000 | SEC 申报 ↗ |
| 2026-06-04 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 150,000 | USD 56.44 | USD 8,466,000 | SEC 申报 ↗ |
| 2026-06-01 | Feeley Kevin | 卖出 (S) | Class A Common Stock | 369 | USD 51.74 | USD 19,092 | SEC 申报 ↗ |
| 2026-06-01 | Feeley Kevin | 期权行权/转换 (M) | Class A Common Stock | 717 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Class A Common Stock, par value $0.0001 per share | 140,000 | USD 43.81 | USD 6,133,400 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | WGS |
| CIK | 0001818331 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8000 Services-Health Services |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 737 transaction lines from 2021-07-22 to 2026-09-17 68 P purchase lines · 395 S sale lines · 274 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.